ProstateUK Profs
@ProstateUKProfs
Followers
4K
Following
2K
Media
2K
Statuses
5K
Here we share news and views from @ProstateUK for our growing professional community who have an interest in prostate disease 🧑🔬 #ProstateCancerUK
UK
Joined November 2013
Thank you to all the researchers and health professionals who continue to drive progress in early prostate cancer diagnosis🩵 Your work is helping shape the evidence and care that will save more men’s lives. Read more about the NSC announcement ➡️ https://t.co/t84KwP3wbK
0
2
4
Could machine learning be a future tool to predict protein-protein interactions in #ProstateCancer? A team including @ProstateUK funded @keyuan1 @GlasgowCS take protein language models a step forward in @NatureComms. Grab a ☕ and read: https://t.co/r0on4vPq7b
0
1
1
Men with certain BRCA gene variations are at higher risk of getting #ProstateCancer 🧬 The UK National Screening Committee now recommends these men should be invited for routine screening. We’ve answered your key questions. ➡️ Learn more: https://t.co/9vYk92cEFv
1
5
11
🗣️ YOUR FEEDBACK MATTERS Share your thoughts on the recent NSC recommendation on prostate cancer screening for men with BRCA gene variations. Please complete this form to help us understand how best to support you and your patients ➡️ https://t.co/6VW5UndV9n
0
0
0
🗣️ YOUR FEEDBACK MATTERS Share your thoughts on the recent NSC recommendation on prostate cancer screening for men with BRCA gene variations. Please complete this form to help us understand how best to support you and your patients ➡️ https://t.co/6VW5UndV9n
0
0
1
Screening takes time but early diagnosis can’t wait. Keep supporting men at risk and stay informed with our latest guidance, education and clinical resources. Sign up to our health professional e-newsletter ➡️ https://t.co/qqzVVg0RKz
0
0
2
📣 We’re looking forward to the discussion session at From Ideas to Innovation, which will explore Equity in Research Career Progression. 🙏We’re grateful to our research community for sharing their insights and experiences. ⬇️ Check out the full agenda. https://t.co/RNbhHyfUFW
0
0
0
💥 Drive better outcomes for men with prostate cancer! Join our Exercise Oncology Leadership Programme - a free hybrid course empowering healthcare professional with leadership skills to embed exercise interventions in care. 🌐 Apply today: https://t.co/zJvFp57JDh
0
0
1
🥼 Meet Prof Hashim Ahmed and Prof Mark Emberton, researchers and clinicians dedicated to improving the way we diagnose men with prostate cancer. Find out more ➡️ https://t.co/lVilioFYZ3
0
2
6
📢Calling all oncologists! Our Clinical Advisory Group is recruiting an oncologist to join the group. Bring your expertise to help shape and improve prostate cancer care. Apply now or share with a colleague 👉
prostatecanceruk.org
Our Clinical Advisory Group is a multidisciplinary panel where members bring their clinical expertise and real-world experience to provide support and insight to teams across Prostate Cancer UK.
0
0
0
🥼 Meet Dr Bunmi Olajide, a GP dedicated to improving cancer care and raising awareness of Black men’s higher risk of prostate cancer. Learn more ➡️ https://t.co/t84KwP2Ymc
0
0
0
🌱 Early-career clinical researchers can apply for one of two CRSG observer roles to learn from leaders, connect nationally & grow your research career in prostate cancer. Deadline: 4pm, Fri 16 Jan
📣 Calling all clinical prostate cancer researchers! The NCRI Prostate Group is now the UK Prostate Cancer Clinical Research Strategy Group - a national platform for collaboration and innovation in prostate cancer research. Find out more: 🔗
0
1
2
A fantastic opportunity for undergraduate students to gain hands-on research experience over the summer 👇
Attention undergrad students! Applications are now OPEN for the JCRC Summer Research Programme! Learn more about how you could spend your summer in our labs at the link below! https://t.co/Oyh2C1reU2
0
2
1
🗣️ YOUR FEEDBACK MATTERS Share your thoughts on the recent NSC recommendation on prostate cancer screening for men with BRCA gene variations. Please complete this form to help us understand how best to support you and your patients ➡️ https://t.co/6VW5UndV9n
0
0
1
Could dose–response model parameters influence identification of bladder regions vulnerable to radiotherapy-induced toxicity? A team led by @PuriTanuj, Prof Marcel van Herk & @Al_McWilliam @UoM_DCS share new findings in @PhysicaMedica. Grab a ☕ & read: https://t.co/SSo0tAZSil
0
0
0
While the NSC has recommended screening only for men with BRCA gene variations, this isn’t the end of the story. Our ongoing research, including TRANSFORM, will provide the evidence needed to expand screening safely in the future. Find out more ➡️ https://t.co/lVilioFYZ3
0
4
6
Our new Black Men’s One-to-One Support Service connects Black men affected by prostate cancer to a volunteer who truly understands their experience. 🩵 Please signpost men in your care to https://t.co/4hFilwmM0a or our phone line 0800 448 0745 to self-refer.
0
0
1
🗣️ YOUR FEEDBACK MATTERS Share your thoughts on the recent NSC recommendation on prostate cancer screening for men with BRCA gene variations. Please complete this form to help us understand how best to support you and your patients ➡️ https://t.co/6VW5UndV9n
0
0
1
The TRANSFORM prostate cancer screening study team Funded by @ProstateUK and @NIHRresearch
@SimonMDLord @ethansgrumps @ChristineKayNew @mgtmccartney TRANSFORM designed to further, ⬇️ biopsy rates (strict biopsy threshold) ⬇️ over diagnosis (biopsy only highly suspicious Prostagram MRI) ⬇️ over treatment (AS for GG1/some GG2) ⬇️ treatment side effects (focal therapy) ⬆️ improve survival (find cancers PSA misses)
1
9
38
Friday’s NSC recommendation is a step toward targeted prostate cancer screening for men with BRCA gene variations. However, many men at higher risk are being missed. Read more ➡️ https://t.co/t84KwP2Ymc
0
1
1